Finoriq research workspace
AETHLON MEDICAL INC (AEMD) SEC Filings & Filing Highlights
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel. Review AEMD SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
- Company
- AETHLON MEDICAL INC (AEMD)
- Ticker
- AEMD
- Market Cap
- $1.6M
- Latest Price
- $0.6016
- Industry
- Medical Devices
AETHLON MEDICAL INC (AEMD) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for AETHLON MEDICAL INC (AEMD).
| Event | Form | Date |
|---|---|---|
| Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under...Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules | 8-K8.01 | 2026-07-08 |
| AETHLON MEDICAL INC: Material agreementOn July 6, 2026, Aethlon Medical, Inc., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase A... | 8-K1.01 | 2026-07-08 |
| Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate UpdateAethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update | 8-K7.01 | 2026-06-10 |
| The legal opinion of Procopio, Cory, Hargreaves & Savitch, LLP relating to the Placement Shares...On December 23, 2025, Aethlon Medical, Inc., a Nevada corporation (the “Company”), filed a prospectus supplement (the “Prospectus Supplemen... | 8-K8.01 | 2026-06-04 |
| Date: March 17, 2026Following recent exercises of certain pre-funded warrants, Aethlon Medical, Inc. has 1,569,110 shares of common stock outstanding as of the... | 8-K8.01 | 2026-03-17 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.